EnzymeRx is a private, clinical stage biotechnology company developing uricase-PEG 20 for the treatment of resistant and refractory gout and related indications in which hyperuricemia plays a causative role.
EnzymeRx Frequently Asked Questions (FAQ)
Where is EnzymeRx's headquarters?
EnzymeRx's headquarters is located at 17 Acadian Avenue, Paramus.
What is EnzymeRx's latest funding round?
EnzymeRx's latest funding round is Other Investors.
Who are the investors of EnzymeRx?
Investors of EnzymeRx include Pequot Capital Mangement.
Who are EnzymeRx's competitors?
Competitors of EnzymeRx include GangaGen, Molmed, Pique Therapeutics, OxThera, Larimar Therapeutics and 7 more.
Compare EnzymeRx to Competitors
Scientists at Epeius Biotechnologies have developed a targeted delivery system (TDS) that can transport genes or other therapeutic agents directly to diseased areas in the body. This pathotropic, or disease-seeking, technology has enabled the company to develop Rexin-G, a tumor-targeted, injectable gene delivery system that has demonstrated remarkable safety and single-agent efficacy in clinical trials internationally. Rexin-G is currently in clinical trials for pancreatic cancer in the U.S. ƒƒ‚ƒš‚" where it has achieved FDA orphan drug status ƒƒ‚ƒš‚" and has accelerated approval in the Philippines for the treatment of all solid tumors that are resistant to standard chemotherapy. The company's international clinical outreach with Rexin-G has enabled us to expedite further demonstrations that Rexin-G is highly active in a broad spectrum of chemo-resistant tumor types with efficacy and excellent safety profiles. The company are a biopharmaceutical company focused on expanding the therapeutic utility and commercialization of the company's pathotropic approach to disease treatment through internal development and commercialization of the company's oncology products and cancer vaccines, and through strategic partnerships in additional areas of oncology, immunology, cardiovascular, ocular, and wound healing applications, precision targeted diagnostics, and stem cell technologies.
Checkpoint Surgical is a medical device company focused on advancing peripheral nerve care. The company offers a range of nerve care products, including nerve stimulators and biomaterials for nerve repair, as well as educational programs for surgeons. Checkpoint Surgical primarily serves the healthcare sector, with a focus on surgical and medical device industries. It was founded in 2009 and is based in Beachwood, Ohio.
OxThera is a biopharmaceutical company focused on developing treatments for rare kidney diseases, specifically targeting Primary Hyperoxaluria. The company's main product, Oxabact, is an orally administered biotherapy designed to reduce oxalate levels in patients by promoting its secretion from plasma into the gut and degrading it there, thereby protecting the kidneys from damage. OxThera primarily serves the healthcare sector, with a focus on providing novel treatment options for rare kidney diseases. It was founded in 2005 and is based in Stockholm, Sweden.
Timi3 Systems, Inc., a biotechnology company, develops a non-invasive transcutaneous ultrasound system for the treatment of patients experiencing an acute myocardial infarction or heart attack. The company specializes in the non-invasive delivery of thrombolytic drugs that hasten the dissolution of thrombus during a myocardial infarction. Timi3 Systems, Inc. was founded in 1999 and is based in Santa Clara, California.
ADV Bioscience is a biotechnology service company engaged in the application of self-developed, public domain technologies and licensed technologies primarily for gene discovery research and validation. The company's focus is offering these technologies primarily to the Chinese market.
Biolog is a company that specializes in microbial identification and characterization, operating within the biotechnology industry. The company offers products and services that enable the characterization of microbial and mammalian cells, as well as the identification of a wide range of bacteria, yeast, and fungi. Biolog primarily serves sectors such as bioprocess and fermentation, environmental monitoring and quality control, brewing, probiotics, drug discovery and diagnostics, and basic research. It was founded in 1984 and is based in Hayward, California.